The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| BIOQ | -37.48% | -55.11% | -14.79% | +17,215% |
| S&P | +14.43% | +77.25% | +12.13% | +2,121% |
Bioqual, Inc. engages in the provision and development of medical research and consulting services to commercial clients and government laboratories. It focuses on animal models of human diseases including COVID-19, Zika, AIDS, Influenza, RSV, Malaria, and other infectious disease areas. The company was founded by John C. Landon on June 1, 1981 and is headquartered in Rockville, MD.
No news articles found for Bioqual.
| Q4 2025 | YOY Change | |
|---|---|---|
| Revenue | $10.98M | -3.7% |
| Gross Profit | $1.01M | 985.2% |
| Gross Margin | 9.16% | 10.2% |
| Market Cap | $34.42M | -42.9% |
| Net Income | -$137.29K | 88.7% |
| EBITDA | $156.67K | 112.7% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q4 2025 | YOY Change | |
|---|---|---|
| Net Cash | $10.34M | -9.8% |
| Accounts Receivable | $12.77M | -19.1% |
| Inventory | 0 | 0.0% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $31.18M | 110.9% |
| Short Term Debt | $3.32M | -1.7% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 0.69% | 5.4% |
| Return On Invested Capital | 4.88% | -2.5% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$2,439.04K | -14.9% |
| Operating Free Cash Flow | -$2,116.96K | -0.4% |
| Metric | Q1 2024 | Q2 2024 | Q4 2025 | YoY Change | |
|---|---|---|---|---|---|
| Price to Earnings | 69.16 | 140.12 | 75.99 | - | |
| Price to Book | 1.52 | 1.11 | 1.07 | 0.96 | -41.25% |
| Price to Sales | 1.08 | 0.82 | 0.84 | 0.74 | -37.68% |
| Price to Tangible Book Value | 1.57 | 1.14 | 1.10 | 0.99 | -41.20% |
| Price to Free Cash Flow TTM | 45.90 | 17.83 | 8.11 | 6.89 | -16.92% |
| Enterprise Value to EBITDA | 33.13 | 87.04 | 35.59 | 361.32 | -768.24% |
| Free Cash Flow Yield | 2.2% | 5.6% | 12.3% | 14.5% | 20.37% |
| Return on Equity | -5.7% | -2.8% | -1.7% | 1.3% | -116.89% |
| Total Debt | $17.50M | $16.54M | $15.55M | $34.50M | 89.99% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
